In vitro and in vivo assessment of antimicrobial, enzymatic, and antifouling properties of self-potent lichen symbiotic bacteria

This study aimed to comprehensively assess the antimicrobial, antifouling, and antibiofilm-forming potential of lichen symbiotic bacteria against marine fouling bacterial strains. A total of 50 lichen-associated bacteria (LAB) isolates were successfully characterized and evaluated for their effectiveness in mitigating biofouling caused by various marine biofoulers. Through a battery of biological assays encompassing enzymatic, antagonistic, antimicrobial, and antifouling assays, 15 LAB isolates were identified based on their antagonist activities. Notably, the strain LAB4 exhibited remarkable performance across all bioassays, demonstrating its proficiency as an antifouling agent. The production of crude LAB extracts was successfully scaled up using a large-scale fermentor and further optimized. Additionally, a phylogenetic analysis of the isolated strain Bacillus proteolyticus D65's 16S ribosomal RNA gene revealed a high query coverage and percentage identity of 92.62% (accession no. MK883171.1). In conclusion, the lichen bacterial symbiotic isolate B. proteolyticus exhibited significant in vitro and in vivo inhibition of foulants. This study highlights the potential of lichens as a valuable source of yet unexplored bacteria. The bacterial consortium associated with Parmotrema sp. holds promise in combatting biofouling, which poses a substantial threat to the maritime industries and their economic stability.